Scoring system stratified patients by recurrence risk of cancer-associated VTE

Cowles, Carey; Fisher, Stacey L.; Harris, Jason
December 2010
Hem/Onc Today;12/25/2010, Vol. 11 Issue 24, p30
The article reports on a scoring system that was able to stratify patients by recurrence risk of cancer-associated venous thromboembolism (VTE).


Related Articles

  • Tinzaparin vs Warfarin for Treatment of Acute Venous Thromboembolism in Patients With Active Cancer. Lee, Agnes Y. Y.; Kamphuisen, Pieter W.; Meyer, Guy; Bauersachs, Rupert; Janas, Mette S.; Jarner, Mikala F.; Khorana, Alok A. // JAMA: Journal of the American Medical Association;8/18/2015, Vol. 314 Issue 7, 10.1001/jama.2015.9243 p677 

    IMPORTANCE Low-molecular-weight heparin is recommended over warfarin for the treatment of acute venous thromboembolism (VTE) in patients with active cancer largely based on results of a single, large trial. OBJECTIVE To study the efficacy and safety of tinzaparin vs warfarin for treatment of...

  • Impact of Pharmacists' Interventions on Prescribing Patterns for the Treatment of VTE in Patients with Cancer. Steward, Vikki M.; Hamid, Hind; Hooker, Kimberly // Journal of Hematology Oncology Pharmacy;Dec2012, Vol. 2 Issue 4, p132 

    Background: Venous thromboembolism (VTE) is a common comorbidity and a significant complication among patients with cancer. Its management can be quite problematic for medical oncologists. Guidelines recommend low-molecular-weight heparin (LMWH) monotherapy for 6 months as the preferred...

  • Hastalarımızda Tromboz Sıklığı ve Literatürün Gözden Geçirilmesi. Urvay, Semiha; Çolak, Dilşen; İmamoğlu, G. İnanç; Ersoy, Uğur; Hacibekiroğlu, İlhan; Köse, Naziyet; Sari, Ebru; Altinbaş, Mustafa // Ortadogu Medical Journal / Ortadogu Tip Dergisi;2012, Vol. 4 Issue 1, p1 

    Aim: Venous thromboembolism occurs commonly in patients with cancer. Among risk factors for thromboembolism are long-term immobilisation, especially in hospital, vascular obstruction, surgery, chemotherapy with or without adjuvant hormone therapy and cancer releated peptides. Cancer is...

  • Silent venous thromboembolism before treatment in endometrial cancer and the risk factors. Satoh, T.; Matsumoto, K.; Uno, K.; Sakurai, M.; Okada, S.; Onuki, M.; Minaguchi, T.; Tanaka, Y. O.; Homma, S.; Oki, A.; Yoshikawa, H. // British Journal of Cancer;9/22/2008, Vol. 99 Issue 7, p1034 

    Venous thromboembolism (VTE) often occurs after surgery and can even occur before surgery in patients with gynaecological malignancies. We investigated the incidence of VTE before treatment of endometrial cancer and associated risk factors. Plasma D-dimer (DD) levels before initial treatment...

  • THE AUTHORS REPLY. Rodegherio, Francesco; Tosetto, Alberto; Frezato, Maurizio // American Journal of Epidemiology;1998, Vol. 147 Issue 6, p606 

    A response from the author of the article "Validated Questionnaire for the Identification of Previous Personal or Familial Venous Thromboembolism," in the previous issue, which discusses the concept of thrombosis is presented.

  • Selecting an anticoagulant for recurrent venous thromboembolism in cancer. Goodin, Susan // American Journal of Health-System Pharmacy;11/15/2005 Supplement 5, Vol. 62, pS10 

    Purpose. The thrombogenicity of newer anticancer agents and the challenges associated with managing cancer patients on warfarin have led to the evaluation of the low-molecular-weight heparins (LMWHs) for primary and secondary prophylaxis in this high-risk patient population. Summary. The first...

  • Management and outcomes of cancer-associated venous thromboembolism in patients with concomitant thrombocytopenia: a retrospective cohort study. Kopolovic, Ilana; Lee, Agnes; Wu, Cynthia // Annals of Hematology;Feb2015, Vol. 94 Issue 2, p329 

    Venous thromboembolism (VTE) and thrombocytopenia are both more common in cancer patients than in general populations. Both the outcomes and optimal management of cancer-associated VTE in thrombocytopenic patients are unknown. The objective of the current study is to describe a cohort of...

  • Importance of findings on the initial evaluation for cancer in patients with symptomatic... Cornuz, Jacques; Pearson, Stephen D. // Annals of Internal Medicine;11/15/96, Vol. 125 Issue 10, p785 

    Discusses the importance of the findings in the initial evaluation of cancer patients with symptomatic idiopathic deep venous thrombosis. Information on studies conducted on the relationship between advanced cancer and deep venous thrombosis; Definition of deep venous thrombosis.

  • Venous Thromboembolism and Cancer. Karpman, Harold L. // Internal Medicine Alert;10/29/2008, Vol. 30 Issue 20, p171 

    The article presents a study which found that previously undiagnosed cancer occurs mostly in patients with an unprovoked venous thromboembolism (VTE) and is more often discovered with an extensive cancer screening technique compared to a limited screening technique.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics